Axsome Therapeutics, Inc.
AXSM
Classificação em ações
#2359
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Preço da ação
$155.84
Valor de mercado
$8.16B
Variação (1 dia)
-0.30%
Variação (1 ano)
20.14%
País
US
Negociar Axsome Therapeutics, Inc. (AXSM)
Categoria
Healthcare
Histórico de preços das ações de Axsome Therapeutics, Inc. (AXSM)
Preço de fecho mais alto: $165.95 em 2026-10-01
Preço de fecho mais baixo: $8.99 em 2015-11-01
Preço de fecho mais baixo: $8.99 em 2015-11-01
Histórico de preços das ações da Axsome Therapeutics, Inc. de 2015 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 25.39% |
| 2025 | 62.10% |
| 2024 | 26.95% |
| 2023 | -4.24% |
| 2022 | 118.74% |
| 2021 | -56.59% |
| 2020 | 11.03% |
| 2019 | 2,538.67% |
| 2018 | -44.64% |
| 2017 | -23.67% |
| 2016 | -25.67% |
| 2015 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $533.13 | 25.02% |
US
|
|
| $235.39 | 776.69% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $889.46 | 9.25% |
NL
|
|
| $289.74 | 1.80% |
BE
|
